6936 Ever-Glory Biotech Shareholder Meeting Resolution Announcement
NQ Score
49/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Ever-Glory Biotech held its 2026 annual general meeting on May 22, approving the 2025 profit distribution, financial statements, amendments to articles, and board re-election.
AI Analysis
Frequently Asked Questions
- Q: Were there changes to the rules regarding lending funds to others?
- A: Yes, amendments to the 'Procedures for Lending Funds to Others' were approved.